Serotype distribution and antibiotic susceptibility of invasive Streptococcus pneumoniae isolates in patients aged 50 years or older in Thailand

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 1, 2014, Pages 2716-2720

  Srifuengfung, Somporn ^a   Phongsamart, Wanatpreeya ^a   Tribuddharat, Chanwit ^a   Chatsuwan, Tanittha ^b   Rungnobhakhun, Pimpha ^c   Sapcharoen, Suwandee ^a   Chokephaibulkit, Kulkanya ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c Microbiological Laboratory   (Thailand)

Author keywords

Antibiotic susceptibility; Pneumococcal conjugate vaccine; Serotypes; Streptococcus pneumoniae; Thailand

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; LINEZOLID; OFLOXACIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; TETRACYCLINE; VANCOMYCIN;

ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; FEMALE; HUMAN; MALE; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; PNEUMOCOCCAL INFECTION; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; THAILAND;

EID: 84896705992     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.26418     Document Type: Article

References (22)

1. Weycker D, Strutton D, Edelsberg J, Sato R, Jackson LA. Clinical and economic burden of pneumococcal disease in older US adults. Vaccine 2010; 28:4955-60; PMID:20576535; http://dx.doi.org/10.1016/j.vaccine.2010.05.030
2. van der Linden M, Reinert RR, Kern WV, Imöhl M. Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children. BMC Infect Dis 2013; 13:70-8; PMID:23384407; http://dx.doi.org/10.1186/1471-2334- 13-70
3. Microbe Monthly-El Paso County Public Health. Use of 13-valent pneumococcal conjugate vaccine (PCV13). Communicable Disease Report. Available from: http://www.elpasocountyhealth.org/sites/default/files/files/services/For- Medical-Providers/Microbe-Monthly-Jan2012.pdf
4. Centers for Disease Control and Prevention (CDC). Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older. MMWR Morb Mortal Wkly Rep 2012; 61:394-5; PMID:22647745
5. CDC. Active Bacterial Core Surveillance. Available from: http://www.cdc.gov/abcs/reports-findings/survreports/spneu09.pdf [cited 10.07.13].
6. Immunization Action Coalition. Pneumococcus: questions and answers. Available from: http://www.ppof kc . com/Fo rms /Pneumoni a%20 Vaccine%20QA.pdf [cited 17.03.13].
7. Hsu LY, Lui SW, Lee JL, Hedzlyn HM, Kong DH, Shameen S, Siti NP, Tan WY, Toh XY, Koh TY, et al. Adult invasive pneumococcal disease pre- and peri-pneumococcal conjugate vaccine introduction in a tertiary hospital in Singapore. J Med Microbiol 2009; 58:101-4; PMID:19074659; http://dx.doi.org/10. 1099/jmm.0.003764-0
8. Orrett FA. Pneumococcal infections in Trinidad: patterns of antimicrobial susceptibility: 1994-2002. Jpn J Infect Dis 2005; 58:20-4; PMID:15728985
9. Muench DF. Pneumococcal infections. eMedicine Infectious Diseases. Available from: http://www.emedicine.medscape.com [cited 16.03.13].
10. Domenech A, Ardanuy C, Calatayud L, Santos S, Tubau F, Grau I, Verdaguer R, Dorca J, Pallares R, Martin R, et al. Serotypes and genotypes of Streptococcus pneumoniae causing pneumonia and acute exacerbations in patients with chronic obstructive pulmonary disease. J Antimicrob Chemother 2011; 66:487-93; PMID:21193476; http://dx.doi.org/10.1093/jac/dkq480
11. Srifeungfung S, Tribuddharat C, Comerungsee S, Chatsuwan T, Treerauthanaweeraphong V, Rungnobhakhun P, Nunthapisud P, Chokephaibulkit K. Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006-2009. Vaccine 2010; 28:3440-4; PMID:20199759; http://dx.doi.org/10.1016/j.vaccine.2010.02.071
12. Kuhlmann A, Theidel U, Pletz MW, von der Schulenburg JM. Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany. Health Econ Rev 2012; 2:4; PMID:22828176; http://dx.doi.org/10.1186/ 2191-1991-2-4
13. Grau I, Ardanuy C, Calatayud L, Rolo D, Domenech A, Liñares J, Pallares R. Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden(1)-ST306. PLoS One 2012; 7:e42595; PMID:22912711; http://dx.doi. org/10.1371/journal.pone.0042595
14. Jauneikaite E, Jefferies JM, Hibberd ML, Clarke SC. Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review. Vaccine 2012; 30:3503-14; PMID:22475858; http://dx.doi.org/10.1016/j.vaccine.2012.03.066
15. Vashishtha VM, Kumar P, Mittal A. Seroepidemiology of Streptococcus pneumoniae in developing countries and issues related to vaccination. J Pediatr Sci 2010; 5:e49
16. Moore CE, Sengduangphachanh A, Thaojaikong T, Sirisouk J, Foster D, Phetsouvanh R, McGee L, Crook DW, Newton PN, Peacock SJ. Enhanced determination of Streptococcus pneumoniae serotypes associated with invasive disease in Laos by using a real-time polymerase chain reaction serotyping assay with cerebrospinal fluid. Am J Trop Med Hyg 2010; 83:451-7; PMID:20810803; http://dx.doi.org/10.4269/ajtmh.2010.10-0225
17. Luján M, Gallego M, Belmonte Y, Fontanals D, Vallès J, Lisboa T, Rello J. Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia. Eur Respir J 2010; 36:1073-9; PMID:20150202; http://dx.doi.org/10.1183/09031936.00176309
18. Dagan R, Givon-Lavi N, Leibovitz E, Greenberg D, Porat N. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis 2009; 199:776-85; PMID:19434927; http://dx.doi.org/10.1086/597044
19. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial and susceptibility testing: CLSI document M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute; 2013.
20. Srifuengfung S, Chokephaibulkit K, Tribuddharat C, Comerungsee S. A description of antimicrobial susceptibility of Streptococcus pneumoniae-Siriraj Hospital, Thailand: 2008. J Med Assoc Thai 2010; 93(Suppl 5):S27-34; PMID:21294379
21. Spellerberg B, Brandt C. Streptococcus. In: Versalovic J, Carroll KC, Funke G, editors. Manual of Clinical Microbiology, 10th ed. Washington, D.C., USA: ASM Press; 2011. p. 331-49.
22. Phongsamart W, Srifeungfung S, Dejsirilert S, Chatsuwan T, Nunthapisud P, Treerauthaweeraphong V, Rungnobhakhun P, Chokephaibulkit K. Serotype distribution and antimicrobial susceptibility of S. pneumoniae causing invasive disease in Thai children younger than 5 years old, 2000-2005. Vaccine 2007; 25:1275-80; PMID:17092618; http://dx.doi.org/10.1016/j.vaccine.2006.10.001